{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:29:21Z","timestamp":1793946561792,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacadv.2026.102619","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:24:47Z","timestamp":1771874687000},"page":"102619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Occupational Physical Work Exposure and Wild-Type Transthyretin Cardiomyopathy"],"prefix":"10.1016","volume":"5","author":[{"given":"Bertil T.","family":"Ladefoged","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-3615","authenticated-orcid":false,"given":"Kevin KW.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen H.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102619_bib1","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib2","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102619_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313158","article-title":"A brief journey through protein misfolding in transthyretin amyloidosis (ATTR amyloidosis)","volume":"22","author":"Gonzalez-Duarte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2026.102619_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101086","article-title":"Age- and sex-related differences in patients with wild-type transthyretin amyloidosis","volume":"3","author":"Mora-Ayestaran","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacadv.2026.102619_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2026.102619_bib7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"Aus dem Siepen","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jjcc.2023.04.019","article-title":"Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy","volume":"82","author":"Klarskov","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2017.1375908","article-title":"Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?","volume":"24","author":"Rubin","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jacadv.2026.102619_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00270302","article-title":"Amyloid deposits in human knee and hip joints","volume":"5","author":"Mitrovic","year":"1985","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jacadv.2026.102619_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2559.1992.tb00914.x","article-title":"Localized deposition of amyloid in articular cartilage","volume":"20","author":"Athanasou","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.jacadv.2026.102619_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/ard.40.1.27","article-title":"Microdeposition of amyloid in the joints","volume":"40","author":"Goffin","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacadv.2026.102619_bib13","first-page":"01","article-title":"Increased occupational exposure to physical stress in wild-type transthyretin amyloid cardiomyopathy - a potential disease promoting mechanism?","volume":"2","author":"Klarskov","year":"2024","journal-title":"Int J Prev Med Care"},{"key":"10.1016\/j.jacadv.2026.102619_bib14","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacadv.2026.102619_bib15","article-title":"Plantar dermal deposition of wild-type transthyretin amyloid (ATTR): a case report of a unique and challenging histopathological manifestation of cutaneous ATTR amyloidosis","volume":"17","author":"Ichimata","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jacadv.2026.102619_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.26444\/aaem\/74315","article-title":"The influence of heavy physical effort on proteolytic adaptations in skeletal and heart muscle and aorta in rats","volume":"25","author":"Gilbert-Matusiak","year":"2018","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.jacadv.2026.102619_bib17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1055\/s-0038-1649965","article-title":"Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages","volume":"74","author":"van den Burg","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacadv.2026.102619_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12265-021-10201-0","article-title":"Wild-type transthyretin cardiac amyloidosis is associated with increased antecedent physical activity","volume":"15","author":"Lee","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jacadv.2026.102619_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib22","first-page":"798","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Pottegard","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jacadv.2026.102619_bib24","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102619_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"10.1016\/j.jacadv.2026.102619_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ije\/dyz110","article-title":"Cohort profile: DOC\u2217X: a nationwide Danish occupational cohort with eXposure data \u2013 an open research resource","volume":"48","author":"Flachs","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaccao.2021.08.009","article-title":"Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey","volume":"3","author":"Nativi-Nicolau","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jacadv.2026.102619_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jchf.2025.03.017","article-title":"Current landscape of therapies for transthyretin amyloid cardiomyopathy","volume":"13","author":"Griffin","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2026.102619_bib29","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102619_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2026.102619_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1536\/ihj.25-068","article-title":"The influence of lifestyle factors on the occurrence of wild-type transthyretin cardiac amyloidosis","volume":"66","author":"Baba","year":"2025","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacadv.2026.102619_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2026.102619_bib33","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.5221","article-title":"Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration","volume":"10","author":"Porcari","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.102619_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/EDE.0b013e31821d0879","article-title":"Left truncation, susceptibility, and bias in occupational cohort studies","volume":"22","author":"Applebaum","year":"2011","journal-title":"Epidemiology"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:51:29Z","timestamp":1793944289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772963X26000360"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102619","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Occupational Physical Work Exposure and Wild-Type Transthyretin Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102619"}}